Deep thinking | Integrated capabilities
Reshaping the future of immuno-oncology
At oNKo-innate, our deep understanding of the immune system is inimitable. Through our technology-enabled, biology-driven approach, we are making discoveries that will underpin the next generation of cancer treatments. Unbound by convention, our mission is to transform bold new ideas into therapies that cure more cancer patients.
ABOUT ONKO-INNATE
Tackling solid tumors: any target, any cell type
With a strong background in academic research, oNKo-innate has emerged as one of Australia’s leading independent immuno-oncology companies. From an initial specialization in natural killer cell therapies, we have expanded to prosecute some of the boldest targets in immuno-oncology.
With three integrated platforms spanning target discovery, computational biology, and therapeutic discovery and development, our unbiased approach allows us to pursue any target, in potentially any cell type. Leveraging our technical prowess and a deep understanding of the immune system, we have developed novel pipeline assets that tackle some of the major obstacles in solid tumor therapy, including toxicity and treatment resistance.
While oncology is our primary focus, our platforms have broader applications in immunology, including autoimmune disease.
OUR SCIENCE
The cancer-immunity cycle is incredibly complex, with cancer cells and immune cells forming a network of regulatory interactions.
At oNKo-Innate, we use our integrated biological and computational platforms to explore and dissect this complex immune network…
Discovering novel targets that orchestrate the immune response to tumors…
And manipulate these to redirect the immune system and improve the anti-cancer response.
Our unparalleled expertise in cancer biology allows us to turn these targets into novel cancer immunotherapies.
With a completely unbiased approach, we can explore any target, in any cell type, to create the most effective therapies. We’re leading the immuno-oncology revolution.
Our Platforms
Functional Genomics and Target Discovery
Our universal functional genomics screening platform encompasses in vitro screens of primary human immune cells, in vivo screens in mice, and immsigHTS screening for novel compound libraries.
Computational Biology
Our computational biology platform is key for the identification and development of novel therapeutic targets, enabling the interrogation of high-dimension and complex data.
Protein Engineering and Biotherapeutics
Our therapeutic discovery platform harnesses advanced protein engineering expertise to generate complex biologics and accelerate small molecule campaigns.
Latest News
